0313U prior authorization | Blue Cross and Blue Shield of Montana
0313U, Oncology (Pancreas) Dna And Mrna Next- Generation Sequencing Analysis Of 74 Genes And Analysis Of Cea (Ceacam5) Gene Expression Pancreatic Cyst Fluid Algorithm Reported As A Categorical Result (Ie Negative Low Probability Of Neoplasia Or Positive High Probability Of Neoplasia), is on the Blue Cross and Blue Shield of Montana commercial prior authorization list. Not a coverage or referral decision.
- Code
- 0313U
- Description
- Oncology (Pancreas) Dna And Mrna Next- Generation Sequencing Analysis Of 74 Genes And Analysis Of Cea (Ceacam5) Gene Expression Pancreatic Cyst Fluid Algorithm Reported As A Categorical Result (Ie Negative Low Probability Of Neoplasia Or Positive High Probability Of Neoplasia)
- Source
- 2026 Commercial Medical Surgical Prior Authorization Code List, Pg 202 Original policy